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Summary The presence of tumour-related monoclonal light chain has been sought in urine as an
immunochemical aid in the diagnosis of B lymphocytic neoplasms. The technique of isoelectric focusing in
agarose followed by immunofixation has been applied to concentrated urines from 41 patients. In chronic
lymphocytic leukaemia involving neoplastic B lymphocytes, monoclonal light chain was detected in 14 out of
19 patients investigated. For 2 of the positive cases (one K light chain type and one A light chain type) the
urinary light chains were compared directly with culture fluids obtained after incubation of the corresponding
neoplastic cells obtained from the patient's peripheral blood: identity of the light chains from urine and cells
was established by isoelectric focusing demonstrating for both patients that the tumour cells were the source
of the urinary light chain.
In patients with non-Hodgkin's lymphoma involving neoplastic B lymphocytes, urinary monoclonal light
chains were found in 7/16 of those studied. Such light chains were not detected in 11 control subjects, in 3
patients with true histiocytic tumours or in 2 patients with enlarged reactive lymph nodes. The technique is
simple to perform and provides information for diagnosis and possibly monitoring of B cell neoplasms.
Most cases of chronic lymphocytic leukaemia
(CLL) and non-Hodgkin's lymphoma (NHL)
represent a proliferation of neoplastic B
lymphocytes (Grey et al., 1971). Such cells are not
generally regarded as secreting cells, and the
majority of immunoglobulin (Ig) synthesized is for
insertion into the plasma membrane (Stevenson,
1976). However, recent studies of such lymphocytes
in vitro have shown that some secretion of Ig does
occur. In the majority of cases of CLL the secreted
material has been shown to be free light chain
(Maino et al., 1977; Gordon et al., 1978) often with
small amounts of pentameric IgM (Stevenson et al.,
1980). In NHL the pattern of secretion is more
complex and appears to depend on the surface Ig
isotypes, but a study by biosynthetic radiolabelling
showed export of free monotypic light chain in 11
out of 27 patients (Hannam-Harris et al., 1980).
If neoplastic B lymphocytes are secreting light
chain it may be found in urine as a monoclonal
product and the amount found should reflect
disease load. Normal urine contains light chains of
both K and A types, which are polyclonal, and are
excreted at a rate of 4mg per 24h (Hemmingsen
& Skaarup, 1975). Thus, examination of urine for
monoclonal light chain is against a background of
polyclonal products.
One method developed in this laboratory for
isolating and identifying the tumour-related light
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chain has been described (Pierson et al., 1980) and
involves specific immunosorption and analytical
electrophoresis. By such a procedure it was possible
to detect 1-2mg of monoclonal light chain in a 24h
urine and 14 out of 31 patients with B lymphocytic
tumours showed positive results. In this report we
have used the more simple but discriminating
procedure of isoelectric focusing with
immunofixation to delineate the monoclonal light
chains in patients' urine from the background of
normal heterogeneous light chain. The method is
highly sensitive and can detect as little as 0.03mg
of light chain per 24h urine, (3pgml-1 of light
chain applied). Out of 41 cases examined 20 were
found to be positive and in 2 cases the origin of the
light chain was demonstrated by identity between
that in urine and that found in culture fluids from
the neoplastic lymphocytes.
Such a simple procedure could be applied in a
routine laboratory to assist diagnosis, particularly
in NHL where histological techniques sometimes
fail to distinguish the nature of the cell of origin.
Materials and methods
Patients
Patients with known or suspected B cell neoplasms
(19CLL, 22NHL) attending clinics at local
hospitals were asked to collect 24h-urine samples.
The clinical background and the surface Ig
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phenotype where known, are summarized in Tables
I and II. Most patients with CLL appeared to have
a B cell neoplasm by the demonstration of one light
chain type at the cell surface by
immunofluorescence. The 2 patients with no
detectable surface Ig showed monotypic light chain
export in vitro when culture fluids were analyzed by
radioimmunoassay (Stevenson et al., 1980) thus
demonstrating their B cell nature.
The NHL patients were classified by using the
system described by Gerard-Marchant et al. (1974)
with staging according to the Ann Arbor
Conference (Carbone, 1971) (Table II). Eleven of
the tumours were of B cell origin as shown by
identification of one light chain type at the cell
surface by immunofluorescence. Fluorescence data
were not available for the remaining 11 patients but
histological examination of 5 further tumour
biopsies (KG, AC, MJ, EK and KH in Table II)
demonstrated a follicular pattern consistent with B
cell origin (Gerard-Marchant et al., 1974). Of the
remaining 6 cases, 3 (WW, PG and EF) were
lymphomas of true histiocytic origin confirmed by
immunoperoxidase studies of tissue sections
(Isaacson et al., 1979), 2 (RR and BW) were
immunologically reactive without tumour
involvement and one (JU) exhibited features of
angioimmunoblastic lymphadenopathy (AILD)
(Lukes & Tindle, 1975).
None of the patients in the series had proteinuria
by routine clinical testing, nor a monoclonal Ig
band in serum or concentrated urine detectable by
conventional electrophoresis or immuno-
electrophoresis. Control urines were collected
from 4 healthy laboratory staff (aged 25-35
years) and a group of 7 hospitalized patients
(aged 46-72 years) who showed no evidence of
lymphocytic disease.
Urine samples
Urine was collected in 24h lots directly into bottles
containing 5 ml of toluene as preservative. Samples
were frozen at -20°C until required. Concentration
of urine ( x 100) was carried out using the
Millipore ultrafiltration unit (Millipore Corp.,
Bedford, Mass.) Losses of light chain by this
procedure were estimated by radioimmunoassay
(Stevenson et al., 1980) and did not exceed 20%.
Isoelectricfocusing
Isoelectric focusing was carried out on composite
agarose polyacrylamide plates. These were prepared
by heating 0.35g of IEF grade agarose (Pharmacia
(Great Britain) Ltd., Hounslow, Middlesex) with
2.0g of 10% non-crosslinked polyacrylamide in
38 ml distilled water, cooling to 75°C and adding
2ml 40% carrier ampholytes pH 3.5-9.5 (LKB-
Produkter AB, Bromma, Sweden). The mixed gel was
then poured into templates, overlaid with Gel Bond
(FMC Corporation, Marine Colloids Division,
Bioproducts, Rockland, Maine) and stored
overnight at 4°C before use. Concentrated urine
samples were centrifuged at 1500g for 15min and
5,l aliquots treated with glycine to give a 1%
solution. Aliquots of 1-8 ,l were applied to the gel.
Gels were placed on the Pharmacia FBE-3000
Flatbed unit with sample wells towards the anode.
Electrode strips were soaked in 0.5 M sodium
hydroxide (cathode) and 0.5 M acetic acid (anode)
and gels were run at 10°C for 20min at 100v
followed by 15 min at 500v.
Immunofixation was carried out by overlaying
the gel with cellulose acetate strips soaked in
specific antibody. Sheep antisera raised against K or
A light chains were purified by immunosorption
(Pierson et al., 1980) and then deaggregated on
columns of Ultrogel AcA 34 (LKB-Produkter AB,
Bromma, Sweden). They were then used at a
concentration of I mgml-1. After exposure for 1 h
in a humid chamber the gels were thoroughly
washed with 0.9% saline and then with distilled
water followed by methanol. After drying at 70°C
gels were stained with 0.3% Coomassie Brilliant
Blue R dissolved in methanol-acetic acid-distilled
water (4:4:1) and destained until the background
was clear.
Autoradiography
This technique was used where the expected
concentration of monoclonal light chain applied to
the gel was 3/,gml-1; sensitivity was increased to
- 4 times that of immunofixation alone. It was
necessary for analysis of concentrated culture fluids.
In this case the gel was treated with sheep antibody
as described above and washed in saline followed
by distilled water. It was then overlaid with a
cellulose acetate strip soaked in the radiolabelled
second antibody. This was a preparation of rabbit
anti-sheep IgG, purified by immunosorption on
Sepharose-sheep IgG and radiolabelled by the
lactoperoxidase-catalyzed iodination using 1251I
(Amersham U.K.) to a specific activity of
2 uCiMg- 1; it was used at a concentration of
25 ugml-1. After 1 h in a humid chamber the gel
was washed and then dried. It was then placed in
contact with X-ray film (X-Omat S, Kodak Ltd.),
in the dark for 2 days before being developed.
Cell culture
Leukaemic lymphocytes were prepared from
peripheral blood of 2 patients (JW and LP in Table
I) with CLL by gradient centrifugation on Ficoll-
Hypaque (Boyum, 1974) as described previously
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Table I Patients with chronic lymphocytic leukaemia
White cell Surface Ig Urinary
Age count Cytotoxic on leukaemic monoclonal
Patient (yr) Sex (109- 1) Stage* drugs cells light chain
J.B. 74 M 92 I - NDt +i
J.Bl. 54 M 22 I - MK ND
A.S. 84 M 27 II - MK +K
T.W. 78 M 110 0 - MDK + K
N.S. 80 F 9.2 II - MK +K
V.M. 64 F 127 II - MK +K
B.S. 77 F 11 0 - MDA ND
E.B. 75 F 17 0 - MDK ND
L.D. 63 M 8 0 - MGK + K
M.L. 74 F 11 I - MK +K
E.L. 68 M 54 II + ND ND
P.M. 65 M 36 III - MDGA +A
E.R. 70 F 9.3 III + MK ND
F.M. 57 M 6.7 IV + MDK + K
H.S. 59 M 90 0 - MK +K
J.W. 74 M 51 I - MDGK + K
D.H. 60 M 50 I - MDGK + K
J.Wi. 85 M 120 I - MDK + K
L.P. 50 M 34 I - MDGA
*Staging was based on clinical assessment (Rai et al., 1975).
tND =not detected.
washed and then resuspended in Eagle's minimal
essential medium (MEM) containing 1% non-
essential amino acids (Flow Laboratories Inc.,
Walkersville, Md.), 2mM L-glutamine, and
100 lIUml1 of both penicillin and streptomycin.
The medium was supplemented with 10% foetal
calf serum and cells were cultured at 2 x 107 ml- 1 at
37°C with gentle swirling. After 6h the cells were
removed by centrifugation and the fluid collected
and concentrated x 10 in an Amicon ultrafiltration
apparatus with a PM 10 membrane (Amicon Corp.,
Scientific Sys. Div., Lexington, Mass.). The fluid
was then analyzed by IEF or stored at -70°C.
Results
Concentrated urine from the 11 control subjects (4
normal and 7 patients with no lymphocytic disease)
showed no evidence of monoclonal light chain by
IEF and immunofixation. The results of analysis of
urine from patients with CLL are shown in Table I.
In 14 out of 19 cases there was clear evidence of
monoclonal light chain which reacted with either
anti-K (11 cases) or anti-A (3 cases). The pattern
obtained was usually of one major band with up to
3 minor bands in the vicinity at evenly spaced
intervals. Similar patterns were obtained with
purified Bence-Jones proteins: charge differences in
monoclonal light chains which can give rise to
electrophoretic heterogeneity have been described
previously (Poulik, 1964). In all the positive urines
only one light chain type was found and in 12 out
of 14 patients it was the same as that found at the
cell surface. The patients JB and EL had no
detectable surface Ig. There was no clear
correlation between detection of monoclonal light
chain and stage of disease, although any cytotoxic
therapy may have obscured such a correlation.
For 2 of the patients (JW and LP) it was possible
to culture the tumour cells obtained from
peripheral blood and to collect the culture fluid for
analysis. Concentrated culture fluid was then
compared with the urinary light chain by IEF and
autoradiography. In both cases the light chains
from culture fluid or urine were of exactly similar
type and mobility on IEF. The results from patient
LP are shown in the Figure: in this case the A chain
was unusually acidic and it can be seen that the
same 2 well-defined bands are present in both
culture fluid and urine. Extra bands in the urine are
visible at the relatively high concentration applied.
The results of analysis of urine from the patients
with NHL are shown in Table II. Assessment is
more difficult in this case due to the heterogeneous
nature of the disease and to the fact that therapy is
often given. In the patients investigated, 7 out of 22
showed a monoclonal light chain. However,
subsequent histological assessment showed that 3
patients (WW, PG and EF in Table II had tumours
involving cells with characteristics of histiocytes610 F.K. STEVENSON et al.
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Figure 1 Comparison by isoelectric focusing of monoclonal A light chains obtained from culture fluid and
urine of patient LP. Fluid obtained after incubating neoplastic lymphocytes from peripheral blood for 6h was
concentrated x 10 and 5,l (A) and 8jl (B) samples were applied to the gel. Urine from the same patient was
concentrated x 50 and 1 l (C), 0.5pl (D) and 0.25/4 (E) aliquots were applied to the gel. After running the gel,
immunofixation was carried out using sheep anti-A antibody followed by radiolabelled rabbit anti-sheep IgG:
detection was by autoradiography.
rather than B lymphocytes, and a further 2 patients
(RR and BW) had enlarged lymph nodes with the
histological appearance of immunological reactivity
rather than tumour involvement. One patient (JU)
showed a histological appearance consistent with
angioimmunoblastic lymphadenopathy. This is a
lymphoproliferative disease not thought to involve
neoplastic B lymphocytes (Lukes & Tindle, 1975).
All 6 of these patients did not have urinary
monoclonal light chains. Thus of the remaining 16
definite B cell neoplasms, 7 showed such light
chains.
Discussion
Studies on neoplastic B lymphocytes in vitro have
demonstrated that they are capable of synthesizing
Ig molecules generally for insertion into the plasma
membrane, but also in small amounts for export
(Stevenson et al., 1980). The nature of the Ig
exported appears to reflect the degree of maturity
of the B lymphocyte, with the less mature B cells
exporting free light chains and the more mature
exporting whole Ig molecules (Hannam-Harris et
al., 1980). In cells exporting an excess of free light
chains it may be expected that they will appear
eventually in the urine where they can both aid in
diagnosis of a B cell tumour and also provide an
index of tumour load (Pierson et al., 1980).
Methods used previously to examine urine for
tumour-related light chains have relied on changes
in the levels of one of the light chain types. Results
then have to be interpreted against a wide range of
KI/ ratios in normal subjects. Using such a
procedure, significant increases in the level of one
of the urinary light chain types were seen in 19 out
of 76 cases of lymphoma and leukaemia (Lindstr6m
et al., 1969).
The presence of such monoclonal light chain in
urine from patients with B cell tumours has beenURINARY MONOCLONAL LIGHT CHAINS IN B CELL TUMOURS 611
Table II Patients with non-Hodgkin's lymphoma
Surface Ig Urinary
Age Histology on on tumour monoclonal
Patient (yr) Sex biopsy* Staget Treatment cells4 light chain
V.E. 37 F CB-CC diffuse IV + ND§
K.G. 36 M CB-CC follicular II - +K
M.H. 39 M CB-CC diffuse I - K +K
N.B. 65 M CB-CC follicular II - MK ND
A.C. 71 F CC follicular IV - - ND
L.R. 78 F CC diffuse III + MA ND
E.K. 57 M CC follicular IV + -+K
K.H. 64 F CB-CC follicular I - - ND
M.D. 49 F CB-CC follicular IV + MK +K
J.H. 62 F CB-CC follicular III - MDK +K
M.J. 63 F CB-CC follicular IV - ND
E.S. 56 F CB diffuse I + GK +K
C.S. 61 M IV - MGK +K
B.S. 51 F Small cell III - ND
E.D. 49 F lymphocytic I - MA ND
A.E. 61 M IV + K ND
W.W. 67 M I - - ND
P.G. 43 M Histiocytic III + - ND
E.F. 70 M IV - - ND
R.R. 49 F Reactive - - ND
B.W. 59 F J- - ND
J.U. 77 M AILD - - ND
*Histological classification was based on the system of Gerard-Marchant et al. (1974): CB
and CC refer to cells of the follicle centre, centroblasts and centrocytes respectively, with CB-
CC indicating a mixture of the 2 cell types. Patterns of tumour cell distribution in the
biopsies are indicated as follicular where follicles are recognizable, or diffuse. AILD:
angioimmunoblastic lymphadenopathy.
tStaging was according to the Ann Arbor Conference (Carbone, 1971).
tData obtained by examination of cell suspensions from fresh tissue biopsies by
immunofluorescence. In some cases there was only sufficient material for light chain analysis.
Dashes indicate that fresh material was not available.
§ND=not detected.
sought in a previous study from this laboratory and
40-50% of patients with CLL and NHL were
found to be positive (Pierson et al., 1980). The
method used, however, involved isolation of the
light chain by immunosorption and was not
applicable on a routine basis. The current report
describes a different method of analysis which
demonstrates monoclonal light chain by a simple
and rapid technique which could be used as a
diagnostic aid.
In CLL, where the incidence of urinary
monoclonal light chains has been described as 15%
when analyzed by conventional electrophoresis or
immunoelectrophoresis (McLaughlin & Hobbs,
1972) the techniqe of isoelectric focusing has
demonstrated a much higher incidence (14 out of
19 patients studied) suggesting that this
immunochemical procedure may assist in diagnosis,
particularly when the surface Ig of the neoplastic
cells in the blood is scanty.
The incidence of monoclonal urinary light chain
in NHL involving B lymphocytes appears to be
lower than for CLL (7 out of 16 patients studied).
Several factors could account for this: 6 of the
patients studied were already on treatment and
although 2 of these did have urinary monoclonal
light chains, the effect of treatment on the
remaining 4 is not known. A further study of
patients before treatment is in progress. Another
factor is the stage of the disease, as a small body
load would not be expected to give rise to
detectable light chain: however no obvious
correlation with disease stage is apparent from
Table II. The third factor is the nature of the
tumour cells, in that the more mature B cells may
not export excess light chain (Hannam-Harris et al.,
1980). Even with these restrictions, the finding of
monoclonal light chain in the urine of a patient
would be a useful immunochemical adjunct to
current diagnostic procedures, although it should be612 F.K. STEVENSON et al.
emphasized that failure to detect such a product
would not preclude a B cell neoplasm. Histological
investigation of biopsy material from patients with
suspected NHL, even with analysis of surface Ig,
may fail to distinguish the nature of the disease and
urine analysis would provide a simple additional
test. Also, for both CLL and NHL the load of a
tumour-related product in urine would give a
measure of total body load and quantitative
estimation of urinary light chain e.g. by
radioimmunoassay during a course of therapy may
be useful in monitoring patients.
One problem which could arise is that of
"idiopathic" Bence-Jones proteinuria, particularly
when Lising such a sensitive method of analysis. The
cxistence of sLIch a state has been questioned
recently (Kyle & Greipp, 1982) since of 7 patients
studied, 5 subsequently demonstrated myeloma
although the time to clinical disease was long and
variable. Further following of patients with urinary
monoclonal light chains should clarify this point.
It is difficult to prove in each case that the
urinary light chains have airisen from the tumour
cells, although where the surface Ig of the tumour
cells has been identified, the light chain in the urinc
has been of the same type (13 CLL and 5 NHL).
However, in 2 of the patients with CLL it has been
shown by examination by IEF of culture fluids
obtained from isolated cells that the neoplastic cells
were the source of the urinary light chains.
A further extension of these findings is that
isolation of monoclonal light chains from selected
patients can be used to raise anti-light chain
isotypes (Pierson et al., 1980). If these react with
idiotypic determinants on the tumour cells as has
been demonstrated for a B lymphocytic neoplasm
of guinea pigs (Stevenson et al., 1977), it may be
possible to use such antibody in analysis of tumour
distribution and possible immunotherapy.
We are grateful to Dr. T.J. Hamblin and Dr. F. Macbeth
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